Literature DB >> 25355845

Epidemiology, clinical features, and genetics of multiple endocrine neoplasia type 2B in a complete population.

Anna Znaczko1, Deirdre E Donnelly1, Patrick J Morrison2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25355845      PMCID： PMC4257749          DOI： 10.1634/theoncologist.2014-0277

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  10 in total

Review 1.  Familial pediatric endocrine tumors.

Authors:  Sarinda Millar; Lisa Bradley; Deirdre E Donnelly; Dennis Carson; Patrick J Morrison
Journal:  Oncologist       Date:  2011-09-20

2.  Gene probe analysis in an informative family with multiple endocrine neoplasia syndrome type 2A (MEN 2A). Improvement in carrier risk estimation.

Authors:  P J Morrison; D R Hadden; A E Hughes; L Kennedy; C J Russell; N C Nevin
Journal:  Q J Med       Date:  1991-07

3.  Presymptomatic screening for MEN-2A.

Authors:  P J Morrison; N C Nevin; A E Hughes; D R Hadden; C F Russell
Journal:  Lancet       Date:  1991-02-02       Impact factor: 79.321

4.  MEN 2A: update on the Northern Ireland and Australian family.

Authors:  P J Morrison; D R Hadden; C J Russell; N C Nevin
Journal:  Henry Ford Hosp Med J       Date:  1989

Review 5.  Multiple endocrine neoplasia type 2B (mucosal neuroma syndrome, Wagenmann-Froboese syndrome).

Authors:  P J Morrison; N C Nevin
Journal:  J Med Genet       Date:  1996-09       Impact factor: 6.318

6.  Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.

Authors:  C Eng; D P Smith; L M Mulligan; M A Nagai; C S Healey; M A Ponder; E Gardner; G F Scheumann; C E Jackson; A Tunnacliffe
Journal:  Hum Mol Genet       Date:  1994-02       Impact factor: 6.150

7.  The optimal age for performing surgery on patients with MEN 2B syndrome.

Authors:  C Gómez I Gavara; J L Ponce Marco; T Belda Ibañez; A Boscà Robledo; C Sebastian Pastor; R Navarro Milla; M Caballero Soto; M Meseguer Anastasio
Journal:  Oncol Lett       Date:  2011-06-29       Impact factor: 2.967

Review 8.  Genetic aspects of familial thyroid cancer.

Authors:  Patrick J Morrison; A Brew Atkinson
Journal:  Oncologist       Date:  2009-05-22

Review 9.  Multiple endocrine neoplasia type 2: an overview.

Authors:  Jessica Moline; Charis Eng
Journal:  Genet Med       Date:  2011-09       Impact factor: 8.822

Review 10.  Multiple endocrine neoplasia type 2.

Authors:  Michael E Gertner; Electron Kebebew
Journal:  Curr Treat Options Oncol       Date:  2004-08
  10 in total
  8 in total

1.  Characteristics of chronic megacolon among patients diagnosed with multiple endocrine neoplasia type 2B.

Authors:  Denys Gibbons; Michael Camilleri; Alfred D Nelson; Deborah Eckert
Journal:  United European Gastroenterol J       Date:  2015-10-13       Impact factor: 4.623

2.  MEN2B Masquerading as Postural Orthostatic Tachycardia Syndrome.

Authors:  Ghazi Khan; John Giacona; Sasan Mirfakhraee; Steven Vernino; Wanpen Vongpatanasin
Journal:  JACC Case Rep       Date:  2022-07-06

3.  Timely diagnosis of multiple endocrine neoplasia 2B by identification of intestinal ganglioneuromatosis: a case series.

Authors:  Medard F M van den Broek; Ester B G Rijks; Peter G J Nikkels; Victorien M Wolters; Robert J J van Es; Hanneke M van Santen; Bernadette P M van Nesselrooij; Menno R Vriens; Rachel S van Leeuwaarde; Gerlof D Valk; Annemarie A Verrijn Stuart
Journal:  Endocrine       Date:  2021-01-21       Impact factor: 3.633

4.  Perioperative Severe Hypotension in a Patient with Multiple Endocrine Neoplasia Type IIb and Bilateral Adrenalectomies: Time to Review the Evidence for Stress Dose Steroids.

Authors:  Jens Tan; Acsa Zavala; Katherine B Hagan; Antoinette Van Meter; Uduak Ursula Williams; Wei Zhang; Pascal Owusu-Agyemang
Journal:  Case Rep Anesthesiol       Date:  2016-11-09

Review 5.  Multiple endocrine neoplasia 2: an overview.

Authors:  B Saravana-Bawan; J D Pasternak
Journal:  Ther Adv Chronic Dis       Date:  2022-02-25       Impact factor: 5.091

6.  Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: an international multicenter study.

Authors:  Louise Vølund Larsen; Delphine Mirebeau-Prunier; Tsuneo Imai; Cristina Alvarez-Escola; Kornelia Hasse-Lazar; Simona Censi; Luciana A Castroneves; Akihiro Sakurai; Minoru Kihara; Kiyomi Horiuchi; Véronique Dorine Barbu; Francoise Borson-Chazot; Anne-Paule Gimenez-Roqueplo; Pascal Pigny; Stephane Pinson; Nelson Wohllk; Charis Eng; Berna Imge Aydogan; Dhananjaya Saranath; Sarka Dvorakova; Frederic Castinetti; Attila Patocs; Damijan Bergant; Thera P Links; Mariola Peczkowska; Ana O Hoff; Caterina Mian; Trisha Dwight; Barbara Jarzab; Hartmut P H Neumann; Mercedes Robledo; Shinya Uchino; Anne Barlier; Christian Godballe; Jes Sloth Mathiesen
Journal:  Endocr Connect       Date:  2020-06       Impact factor: 3.335

7.  Incidence and prevalence of multiple endocrine neoplasia 2A in Denmark 1901-2014: a nationwide study.

Authors:  Jes Sloth Mathiesen; Jens Peter Kroustrup; Peter Vestergaard; Kirstine Stochholm; Per Løgstrup Poulsen; Åse Krogh Rasmussen; Ulla Feldt-Rasmussen; Sten Schytte; Henrik Baymler Pedersen; Christoffer Holst Hahn; Jens Bentzen; Sören Möller; Mette Gaustadnes; Maria Rossing; Finn Cilius Nielsen; Kim Brixen; Anja Lisbeth Frederiksen; Christian Godballe
Journal:  Clin Epidemiol       Date:  2018-10-12       Impact factor: 4.790

8.  Variability in Medullary Thyroid Carcinoma in RET L790F Carriers: A Case Comparison Study of Index Patients.

Authors:  Jes Sloth Mathiesen; Søren Grønlund Nielsen; Åse Krogh Rasmussen; Katalin Kiss; Karin Wadt; Anne Pernille Hermann; Morten Frost Nielsen; Stine Rosenkilde Larsen; Klaus Brusgaard; Anja Lisbeth Frederiksen; Christian Godballe; Maria Rossing
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-28       Impact factor: 5.555
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.